139 related articles for article (PubMed ID: 7678410)
21. Generation of a monoclonal antibody to P-glycoprotein peptides using tuberculin-PPD as a carrier.
Bashir I; Sikora K; Foster CS
Virchows Arch; 1998 Mar; 432(3):279-87. PubMed ID: 9532008
[TBL] [Abstract][Full Text] [Related]
22. Elimination of drug-resistant myeloma tumor cell lines by monoclonal anti-P-glycoprotein antibody and rabbit complement.
Kulkarni SS; Wang ZM; Spitzer G; Taha M; Hamada H; Tsuruo T; Dicke KA
Blood; 1989 Nov; 74(6):2244-51. PubMed ID: 2572283
[TBL] [Abstract][Full Text] [Related]
23. Possibility of the reversal of multidrug resistance and the avoidance of side effects by liposomes modified with MRK-16, a monoclonal antibody to P-glycoprotein.
Matsuo H; Wakasugi M; Takanaga H; Ohtani H; Naito M; Tsuruo T; Sawada Y
J Control Release; 2001 Nov; 77(1-2):77-86. PubMed ID: 11689261
[TBL] [Abstract][Full Text] [Related]
24. Identification of residues in the first cytoplasmic loop of P-glycoprotein involved in the function of chimeric human MDR1-MDR2 transporters.
Currier SJ; Kane SE; Willingham MC; Cardarelli CO; Pastan I; Gottesman MM
J Biol Chem; 1992 Dec; 267(35):25153-9. PubMed ID: 1360983
[TBL] [Abstract][Full Text] [Related]
25. Characterization and epitope mapping of several new anti-P-glycoprotein monoclonal antibodies.
Shapiro AB; Duthie M; Childs S; Okubo T; Ling V
Int J Cancer; 1996 Jul; 67(2):256-63. PubMed ID: 8760596
[TBL] [Abstract][Full Text] [Related]
26. Regression of established tumors expressing P-glycoprotein by combinations of adriamycin, cyclosporin derivatives, and MRK-16 antibodies.
Watanabe T; Naito M; Kokubu N; Tsuruo T
J Natl Cancer Inst; 1997 Apr; 89(7):512-8. PubMed ID: 9086008
[TBL] [Abstract][Full Text] [Related]
27. Cross-reactivity of C219 anti-p170(mdr-1) antibody with p185(c-erbB2) in breast cancer cells: cautions on evaluating p170(mdr-1).
Liu B; Sun D; Xia W; Hung MC; Yu D
J Natl Cancer Inst; 1997 Oct; 89(20):1524-9. PubMed ID: 9337349
[TBL] [Abstract][Full Text] [Related]
28. The extracellular loop between TM5 and TM6 of P-glycoprotein is required for reactivity with monoclonal antibody UIC2.
Zhou Y; Gottesman MM; Pastan I
Arch Biochem Biophys; 1999 Jul; 367(1):74-80. PubMed ID: 10375401
[TBL] [Abstract][Full Text] [Related]
29. Major photoaffinity drug labeling sites for iodoaryl azidoprazosin in P-glycoprotein are within, or immediately C-terminal to, transmembrane domains 6 and 12.
Greenberger LM
J Biol Chem; 1993 May; 268(15):11417-25. PubMed ID: 8098711
[TBL] [Abstract][Full Text] [Related]
30. In vitro bone marrow purging of multidrug-resistant cells with a mouse monoclonal antibody directed against Mr 170,000 glycoprotein and a saporin-conjugated anti-mouse antibody.
Dinota A; Tazzari PL; Michieli M; Visani G; Gobbi M; Bontadini A; Tassi C; Fanin R; Damiani D; Grandi M
Cancer Res; 1990 Jul; 50(14):4291-4. PubMed ID: 1694719
[TBL] [Abstract][Full Text] [Related]
31. Transmembrane organization of mouse P-glycoprotein determined by epitope insertion and immunofluorescence.
Kast C; Canfield V; Levenson R; Gros P
J Biol Chem; 1996 Apr; 271(16):9240-8. PubMed ID: 8621583
[TBL] [Abstract][Full Text] [Related]
32. Characterization of a new monoclonal antibody F4 detecting cell surface epitope and P-glycoprotein in drug-resistant human tumor cell lines.
Chu TM; Kawinski E; Lin TH
Hybridoma; 1993 Aug; 12(4):417-29. PubMed ID: 7503940
[TBL] [Abstract][Full Text] [Related]
33. Membrane topology of P-glycoprotein as determined by epitope insertion: transmembrane organization of the N-terminal domain of mdr3.
Kast C; Canfield V; Levenson R; Gros P
Biochemistry; 1995 Apr; 34(13):4402-11. PubMed ID: 7535563
[TBL] [Abstract][Full Text] [Related]
34. Functionally active homodimer of P-glycoprotein in multidrug-resistant tumor cells.
Naito M; Tsuruo T
Biochem Biophys Res Commun; 1992 May; 185(1):284-90. PubMed ID: 1350903
[TBL] [Abstract][Full Text] [Related]
35. Production and characterization of monoclonal antibodies to simian immunodeficiency virus envelope glycoproteins.
Babas T; Le Grand R; Dormont D; Bahraoui E
AIDS Res Hum Retroviruses; 1997 Sep; 13(13):1109-19. PubMed ID: 9282816
[TBL] [Abstract][Full Text] [Related]
36. High-level expression of MRK 16 and MRK 20 murine monoclonal antibody-define proteins (170,000-180,000 P-glycoprotein and 85,000 protein) in leukaemias and malignant lymphomas.
Sugawara I; Kodo H; Ohkochi E; Hamada H; Tsuruo T; Mori S
Br J Cancer; 1989 Oct; 60(4):538-41. PubMed ID: 2572270
[TBL] [Abstract][Full Text] [Related]
37. Common expression of the multidrug resistance marker P-glycoprotein in B-cell chronic lymphocytic leukaemia and correlation with in vitro drug resistance.
Sparrow RL; Hall FJ; Siregar H; Van der Weyden MB
Leuk Res; 1993 Nov; 17(11):941-7. PubMed ID: 7901453
[TBL] [Abstract][Full Text] [Related]
38. Cytoplasmic orientation and two-domain structure of the multidrug transporter, P-glycoprotein, demonstrated with sequence-specific antibodies.
Yoshimura A; Kuwazuru Y; Sumizawa T; Ichikawa M; Ikeda S; Uda T; Akiyama S
J Biol Chem; 1989 Sep; 264(27):16282-91. PubMed ID: 2476441
[TBL] [Abstract][Full Text] [Related]
39. Isolation of antigenic mimics of MDR1-P-glycoprotein by phage-displayed peptide libraries.
Poloni F; Romagnoli G; Cianfriglia M; Felici F
Int J Cancer; 1995 May; 61(5):727-31. PubMed ID: 7768648
[TBL] [Abstract][Full Text] [Related]
40. Reversal of multidrug resistance in human colon cancer cells expressing the human MDR1 gene by liposomes in combination with monoclonal antibody or verapamil.
Sela S; Husain SR; Pearson JW; Longo DL; Rahman A
J Natl Cancer Inst; 1995 Jan; 87(2):123-8. PubMed ID: 7707383
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
